WINTON GROUP Ltd Has $1.93 Million Stock Holdings in Teladoc Health, Inc. $TDOC

WINTON GROUP Ltd raised its position in Teladoc Health, Inc. (NYSE:TDOC) by 402.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,100 shares of the health services provider’s stock after purchasing an additional 181,900 shares during the quarter. WINTON GROUP Ltd’s holdings in Teladoc Health were worth $1,926,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Nykredit A S bought a new stake in shares of Teladoc Health in the 2nd quarter valued at approximately $27,000. HighTower Advisors LLC lifted its stake in Teladoc Health by 20.8% in the second quarter. HighTower Advisors LLC now owns 16,808 shares of the health services provider’s stock valued at $143,000 after acquiring an additional 2,893 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Teladoc Health in the second quarter valued at approximately $1,447,000. California State Teachers Retirement System grew its position in Teladoc Health by 512.0% in the second quarter. California State Teachers Retirement System now owns 1,679,701 shares of the health services provider’s stock worth $14,244,000 after acquiring an additional 1,405,260 shares in the last quarter. Finally, Ameritas Advisory Services LLC acquired a new position in shares of Teladoc Health during the 2nd quarter worth $68,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

NYSE:TDOC opened at $6.16 on Friday. The stock has a market cap of $1.12 billion, a P/E ratio of -6.22 and a beta of 2.12. Teladoc Health, Inc. has a one year low of $4.40 and a one year high of $9.89. The company has a fifty day moving average price of $7.51 and a 200 day moving average price of $6.75.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same period last year, the business posted ($0.19) EPS. The business’s quarterly revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, equities research analysts anticipate that Teladoc Health, Inc. will post -0.9 EPS for the current year.

Analyst Ratings Changes

TDOC has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Canaccord Genuity Group cut their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Bank of America raised their target price on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Finally, Citigroup decreased their price target on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research note on Monday, August 3rd. Five investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $7.54.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.